RedHill Biopharma reported $-4.22M in Operating Profit for its fiscal quarter ending in June of 2024.





Operating Profit Change Date
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD 56.04M 63.93M Dec/2025
Cronos Group USD -7.06M 62.31M Dec/2025
RedHill Biopharma USD -4.22M 1.8M Jun/2024